Log in to save to my catalogue

Hypoxia increases gefitinib-resistant lung cancer stem cells through the activation of insulin-like...

Hypoxia increases gefitinib-resistant lung cancer stem cells through the activation of insulin-like...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1492273942

Hypoxia increases gefitinib-resistant lung cancer stem cells through the activation of insulin-like growth factor 1 receptor

About this item

Full title

Hypoxia increases gefitinib-resistant lung cancer stem cells through the activation of insulin-like growth factor 1 receptor

Publisher

United States: Public Library of Science

Journal title

PloS one, 2014-01, Vol.9 (1), p.e86459

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Accumulating evidence indicates that a small population of cancer stem cells (CSCs) is involved in intrinsic resistance to cancer treatment. The hypoxic microenvironment is an important stem cell niche that promotes the persistence of CSCs in tumors. Our aim here was to elucidate the role of hypoxia and CSCs in the resistance to gefitinib in non-sm...

Alternative Titles

Full title

Hypoxia increases gefitinib-resistant lung cancer stem cells through the activation of insulin-like growth factor 1 receptor

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_1492273942

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1492273942

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0086459

How to access this item